Treatment with GLP-1 receptor agonists did not increase the incidence of adverse gastrointestinal outcomes in patients with inflammatory bowel disease.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/are-glp-1s-safe-gi-health-inflammatory-bowel-disease-2025a1000mj9?src=rss
Author :
Publish date : 2025-08-26 15:17:00
Copyright for syndicated content belongs to the linked Source.
